Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis

K. A. Papp, H. Bachelez, A. Blauvelt, K. L. Winthrop, R. Romiti, M. Ohtsuki, N. Acharya, D. K. Braun, L. Mallbris, F. Zhao, W. Xu, C. D. Walls, B. Strober

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences